Tyra Biosciences, Inc.
TYRA
$25.28
$0.261.04%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 9.81M | 8.53M | 8.33M | 7.48M | 7.14M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 49.00M | 42.00M | 36.52M | 32.94M | 31.45M |
| Operating Income | -49.00M | -42.00M | -36.52M | -32.94M | -31.45M |
| Income Before Tax | -45.56M | -39.31M | -33.83M | -29.87M | -28.10M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -45.56M | -39.31M | -33.83M | -29.87M | -28.10M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -45.56M | -39.31M | -33.83M | -29.87M | -28.10M |
| EBIT | -49.00M | -42.00M | -36.52M | -32.94M | -31.45M |
| EBITDA | -48.87M | -41.86M | -36.38M | -32.81M | -31.31M |
| EPS Basic | -0.69 | -0.64 | -0.57 | -0.50 | -0.47 |
| Normalized Basic EPS | -0.43 | -0.40 | -0.35 | -0.31 | -0.29 |
| EPS Diluted | -0.69 | -0.64 | -0.57 | -0.50 | -0.47 |
| Normalized Diluted EPS | -0.43 | -0.40 | -0.35 | -0.31 | -0.29 |
| Average Basic Shares Outstanding | 65.99M | 61.75M | 59.83M | 59.67M | 59.55M |
| Average Diluted Shares Outstanding | 65.99M | 61.75M | 59.83M | 59.67M | 59.55M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |